TESTSAMMELVORRICHTUNG

European patent · EP4209180 · In force

Register entry

Publication number
EP4209180
Application number
EP22174533
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 20, 2022
Published
Jul 12, 2023
Granted
Apr 1, 2026
Protection ends at the latest
May 19, 2042
Next annual fee due
May 31, 2026
IPC classes
A61B 10/02 (2006.01)
A61B 10/00 (2006.01)
A61B 5/15 (2006.01)
G01N 1/02 (2006.01)
A61F 13/38 (2006.01)
Priority
CN 202210024877 10.01.2022
US 202263300811 P 19.01.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.04.2026

Parties

Holder

Zhejiang Orient Gene Biotech Co., Ltd

No. 3787, East Yangguang Avenue, Dipu Street, Anji Huzhou Zhejiang 313300, CN

Inventor

FANG, Jianqiu

Huzhou, 313300, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.